Analysis on prognosis of endovascular treatment in moderate and severe patients with acute basilar artery occlusion
-
摘要: 目的 探讨急性中重症基底动脉闭塞(BAO)患者血管内治疗的安全性及有效性。 方法 回顾性分析行血管内治疗的28例急性BAO昏迷患者的临床资料,按术前症状分为中等症状组(昏迷不合并四肢瘫)17例及重症组(昏迷合并四肢瘫)11例,统计患者一般情况、术前状态、治疗方式、血管成功再通率、术后脑实质出血发生率及术后3个月改良Rankin量表(mRS)分级。 结果 28例患者中20例(71.4%)为单纯栓塞性闭塞,行支架取栓治疗, 8例(28.6%)为粥样硬化性狭窄继发闭塞, 2例导管通过后血管再通, 6例支架取栓后行球囊扩张成形及补救支架植入; 28例患者中,成功开通血管26例(92.9%), 中等症状组及重症组各有1例开通失败(2例患者均死亡); 中等症状组及重症组各有1例发生术后脑实质出血(2例患者均死亡); 术后3个月中等症状组预后良好(mRS分级0~2级)6例(35.3%), 重症组无1例预后良好; 中等症状组3例(17.6%)死亡,重症组6例(54.5%)死亡。 结论 昏迷不合并四肢瘫的急性BAO患者行血管内治疗安全有效,昏迷合并四肢瘫BAO患者行血管内治疗不能改善术后3个月的预后。Abstract: Objective To investigate the safety and efficacy of endovascular therapy for moderate and severe patients with acute basilar artery occlusion(BAO). Methods The data of 28 coma patients with acute BAO treated by endovascular therapy was retrospectively analyzed. According to preoperative symptoms, 17 coma cases without tetraplegia were selected as moderate group and 11 coma cases with tetraplegia were selected as severe group. The baseline data, preoperative status, treatment methods, successful recanalization rate, occurrence of hemorrhage of brain parenchyma, and modified Rankin scale(mRS)grading after 3 month were recorded. Results Out of the 28 patients, 20(71.4%)presented as simple embolistic occlusion, and were treated by stent embolism removal, 8(28.6%)as intracranial atherosclerosis-related occlusions, among whom 2(7.1%)were recanalized after the passing of catheter, and the other 6(21.4%)were treated with balloon dilatation or stent implantation after stent thrombectomy. Twenty-six patients(92.9%)obtained successful revascularization, there was one case failed to get revascularization in moderate group and severe group, and both patients were dead. At the same time, there was one patient with parenchymal hemorrhage after operation in each group, and the two patients were dead. At 3-month followed-up, 6 patients(35.3%)presented as good prognosis in the moderate group(mRS classification ranging from 0 to 2 grading), and none with good prognosis occurred in the severe group.There were 3 deaths(17.6%)in moderate group and 6(54.5%)in severe group. Conclusion Endovascular therapy is safe and effective for coma patients without tetraplegia caused by acute BAO. But it can't improve the 3-month prognosis for coma patients with tetraplegia.
-
Keywords:
- basilar artery occlusion /
- coma /
- endovascular therapy /
- prognosis
-
-
Sheng K, Tong M. Therapy for acute basilar artery occlusion: a systematic review and meta-analysis[J]. F1000Res, 2019, 8: 165-165.
Schonewille W J, Algra A, Serena J, et al. Outcome in patients with basilar artery occlusion treated conventionally[J]. J Neurol Neurosurg Psychiatry, 2005, 76(9): 1238-1241.
Schonewille W J, Wijman C A, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study(BASICS): a prospective registry study[J]. Lancet Neurol, 2009, 8(8): 724-730.
Sairanen T, Strbian D, Soinne L, et al. Intravenous thrombolysis of basilar artery occlusion: predictors of recanalization and outcome[J]. Stroke, 2011, 42(8): 2175-2179.
Liu X F, Dai Q L, Ye R D, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion(BEST): an open-label, randomised controlled trial[J]. Lancet Neurol, 2020, 19(2): 115-122.
Dorňák T, Herzig R, Kuliha M, et al. Endovascular treatment of acute basilar artery occlusion: time to treatment is crucial[J]. Clin Radiol, 2015, 70(5): e20-e27.
Gory B, Mazighi M, Labreuche J, et al. Predictors for mortality after mechanical thrombectomy of acute basilar artery occlusion[J]. Cerebrovasc Dis, 2018, 45(1/2): 61-67.
Berkhemer O A, Fransen P S, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372(1): 11-20.
Campbell B C, Mitchell P J, Kleinig T J, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med, 2015, 372(11): 1009-1018.
Goyal M, Demchuk A M, Menon B K, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015, 372(11): 1019-1030.
Jovin T G, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015, 372(24): 2296-2306.
Saver J L, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med, 2015, 372(24): 2285-2295.
Nogueira R G, Frei D, Kirmani J F, et al. Safety and efficacy of a 3-dimensional stent retriever with aspiration-based thrombectomy vs aspiration-based thrombectomy alone in acute ischemic stroke intervention: a randomized clinical trial[J]. JAMA Neurol, 2018, 75(3): 304-311.
Zaidat O O, Bozorgchami H, Ribó M, et al. Primary results of the multicenter ARISE Ⅱ study(analysis of revascularization in ischemic stroke with EmboTrap)[J]. Stroke, 2018, 49(5): 1107-1115.
Kang D H, Jung C, Yoon W, et al. Endovascular thrombectomy for acute basilar artery occlusion: a multicenter retrospective observational study[J]. J Am Heart Assoc, 2018, 7(14): e009419.
Wang L, Shi W C, Su Z G, et al. Endovascular treatment of severe acute basilar artery occlusion[J]. J Clin Neurosci, 2015, 22(1): 195-198.
曾德华. 椎基底动脉狭窄对患者后循环脑梗死及预后的影响研究[J]. 实用临床医药杂志, 2017, 21(11): 28-30 , 41.
Bouslama M, Haussen D C, Aghaebrahim A, et al. Predictors of good outcome after endovascular therapy for vertebrobasilar occlusion stroke[J]. Stroke, 2017, 48(12): 3252-3257.
李文波, 魏立平, 张耀慧, 等. 急性院内基底动脉闭塞所致呼吸心跳骤停血管内治疗1例[J]. 中国卒中杂志, 2018, 13(7): 743-747. Long J W, Qin H, Zhang H Q. Evaluation of recanalisation treatment on posterior circulation ischemic stroke by Solitaire device-A multicenter retrospective study[J]. Neurol Neurochir Pol, 2017, 51(3): 208-213.
-
期刊类型引用(31)
1. 黄奇峰，郑鹏程，戴燕玲. 二甲双胍、阿卡波糖分别联用厄贝沙坦治疗糖尿病合并高血压的临床效果比较. 糖尿病新世界. 2024(04): 56-59+66 . 
百度学术
2. 孙燕，张新菊，李雁. 卡格列净在基层糖尿病慢病管理中的疗效观察. 兵团医学. 2024(01): 54-56 . 百度学术
3. 黄延峰，钟荣惠. 甘精胰岛素搭配阿卡波糖和二甲双胍对糖尿病控制和氧化应激的影响研究. 现代医学与健康研究电子杂志. 2024(12): 51-54 . 百度学术
4. 程继华，孟俊娜，雷巧玲. 艾塞那肽治疗2型糖尿病的疗效及对胰岛素抵抗与糖脂代谢的影响研究. 中国医学工程. 2024(08): 88-92 . 百度学术
5. 贾志壮. 阿卡波糖联合二甲双胍治疗2型糖尿病的效果. 名医. 2024(09): 165-167 . 百度学术
6. 黄伟玲. 阿卡波糖联合二甲双胍治疗2型糖尿病对免疫功能及不良反应的影响. 临床合理用药. 2024(28): 103-105+115 . 百度学术
7. 任喆. 阿卡波糖联合二甲双胍在社区糖尿病患者糖代谢控制中的应用效果. 中国社区医师. 2024(32): 26-28 . 百度学术
8. 张秀丽，余玉花，张文帝. 二甲双胍联合阿卡波糖对2型糖尿病患者免疫功能、糖脂代谢的影响. 糖尿病新世界. 2024(18): 86-88+92 . 百度学术
9. 林钧，陈玮，刘进清. 视网膜激光光凝术与阿卡波糖联合治疗糖尿病性黄斑水肿的临床疗效. 糖尿病新世界. 2024(23): 187-190 . 百度学术
10. 岳斌，张巍，徐丽，郑华东，李明. 二甲双胍联合阿卡波糖治疗2型糖尿病的疗效及对免疫功能和NLRP3水平的影响. 海南医学. 2023(01): 14-18 . 百度学术
11. 耿瑶. 探究达格列净治疗2型糖尿病并心衰的临床疗效及其对炎性因子、血管内皮功能的影响. 黑龙江医学. 2023(05): 547-550 . 百度学术
12. 王鑫. 阿卡波糖联合二甲双胍治疗2型糖尿病的临床疗效观察. 现代诊断与治疗. 2023(01): 64-66+69 . 百度学术
13. 卢洁菲. 阿卡波糖联合二甲双胍对2型糖尿病患者免疫功能及炎性因子的影响. 甘肃医药. 2023(04): 318-319+325 . 百度学术
14. 景珊. 二甲双胍联合阿卡波糖用于糖尿病治疗的疗效及对HbA1c、FPG水平的影响分析. 糖尿病新世界. 2023(09): 76-79 . 百度学术
15. 孙嘉婧，于湘英，马子良. 阿卡波糖与二甲双胍在社区糖尿病治疗中的效果及对血糖的影响探析. 糖尿病新世界. 2023(10): 108-111+115 . 百度学术
16. 卢凯丽，宋瑞捧，姜惠惠，高红红. 阿卡波糖联合维格列汀治疗初治2型糖尿病的效果及对糖脂代谢的影响. 中国实用医刊. 2023(14): 109-112 . 百度学术
17. 方信英. 二甲双胍联合阿卡波糖在2型糖尿病患者中的应用效果分析. 糖尿病新世界. 2023(23): 81-84 . 百度学术
18. 仲伟慧. 阿卡波糖联合二甲双胍治疗2型糖尿病的疗效分析. 中国社区医师. 2022(06): 76-77+80 . 百度学术
19. 刘燕君，朱明敏，陈亚东. 二甲双胍与预混胰岛素联用对2型糖尿病患者血糖指标水平与不良反应的影响. 糖尿病新世界. 2022(05): 68-71 . 百度学术
20. 刘婷，王莹，杨召娣，陈继芳. 阿卡波糖联合二甲双胍治疗2型糖尿病对患者血糖水平、胰岛功能的影响. 现代医学与健康研究电子杂志. 2022(12): 142-144 . 百度学术
21. 王云枫，王彦贺. 阿卡波糖对2型糖尿病患者血脂及尿酸代谢的影响. 哈尔滨医药. 2022(03): 62-63 . 百度学术
22. 王学光. 二甲双胍联合阿卡波糖治疗2型糖尿病临床疗效分析. 糖尿病新世界. 2022(11): 102-105 . 百度学术
23. 陈聪，梁黎黎. 有氧-抗阻运动指导联合降糖药物对老年糖尿病患者的应用效果. 现代医学与健康研究电子杂志. 2022(21): 141-144 . 百度学术
24. 张建，范文文. DPP-4抑制剂联合阿卡波糖治疗初诊老年T2DM患者的疗效分析. 国际医药卫生导报. 2022(23): 3388-3391 . 百度学术
25. 黄文新. 瑞格列奈结合二甲双胍治疗2型糖尿病的疗效及对患者血糖水平的影响. 糖尿病新世界. 2021(07): 87-89 . 百度学术
26. 阳玲，黄冠军，方涛，柴振华，朱红艳. 二甲双胍联合阿格列汀或阿卡波糖治疗2型糖尿病的疗效对比. 药品评价. 2021(10): 621-623 . 百度学术
27. 徐露，章晓君. 阿卡波糖联合二甲双胍治疗糖尿病前期患者的效果分析. 现代医学与健康研究电子杂志. 2021(15): 51-53 . 百度学术
28. 房思思，屈桂茹. 拜糖平和二甲双胍治疗2型糖尿病的有效性及安全性研究. 中国药物滥用防治杂志. 2021(05): 682-684+703 . 百度学术
29. 周芸，刘路. 阿卡波糖联合二甲双胍对2型糖尿病患者血糖与肠促胰岛素水平的影响. 现代医学与健康研究电子杂志. 2021(18): 45-47 . 百度学术
30. 李黎，张瑞. 阿卡波糖联合二甲双胍用于治疗2型糖尿病临床效果分析. 世界复合医学. 2021(10): 195-198 . 百度学术
31. 宋先梅. 二甲双胍结合阿卡波糖治疗初发2型糖尿病伴高脂血症的临床效果分析. 中国现代药物应用. 2021(23): 139-141 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 329
- HTML全文浏览量: 93
- PDF下载量: 7
- 被引次数: 31
下载:
苏公网安备 32100302010246号
